Acupuncture for Sexual Dysfunction
Acupuncture in Premenopausal Women With Hypoactive Sexual Desire Disorder: A Prospective Cohort
1 other identifier
interventional
15
1 country
1
Brief Summary
Female Sexual Dysfunction (FSD) affects up to 43% of women in the United States and Hypoactive Sexual Desire Disorder (HSDD) is the most common form. There is no standardized treatment for this condition. We know that alternative therapies such as acupuncture have been beneficial to women suffering from urinary incontinence, chronic lower back pain, and migraines. We hypothesize that the quality of life for premenopausal women with hypoactive sexual desire disorder (HSDD) will improve with initiation of acupuncture therapy for a duration of 5-weeks. Validated questionnaires are administered at the time of enrollment and 1 week after the final acupuncture session as the method of analyzing our primary outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 26, 2014
CompletedFirst Posted
Study publicly available on registry
February 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedOctober 17, 2014
February 1, 2014
1.4 years
January 26, 2014
October 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Female Sexual Function Index (FSFI)
Determined by a change in the desire domain of the Female Sexual Function Index (FSFI) from baseline at enrollment to study completion at 6 weeks after initiation of intervention.
6 weeks
Secondary Outcomes (5)
Female Sexual Distress Scale (FSDS-R)
6 weeks
Short Form-12 (SF-12)
6 weeks
Generalized Anxiety-Disorder-7 (GAD-7) and Prime Health Questionnaire-9 (PHQ-9)
6 weeks
World Health Organization Quality of Life- BREF (WHOQOL)
6 weeks
Patient Global Impression of Improvement (PGI-I)
6 weeks
Study Arms (1)
Acupuncture
EXPERIMENTALAcupuncture Therapy \- twice weekly sessions for 5 weeks: 1st session 60 minutes with remaining 9 session approximately 45 minutes each. Physical exam at 1st session includes evaluation of peripheral pulses, head, neck, throat/tongue. No pelvic exam required.
Interventions
Acupuncture Therapy - Initial Evaluation History including: chief complaint, diet, level of diaphoresis, water intake, digestive function, menstrual cycling, sleep habits, overall mood. Physical Exam: inspection of tongue and palpation of central and peripheral pulses. Chinese Diagnoses for Female Sexual Dysfunction: Kidney Yang Deficiency; Liver Qi Stagnation; Generalized Blood Deficiency; Spleen Yang Deficiency; Heart Fire \- Subsequent Sessions 25 minute sessions, twice weekly, for 5 weeks = total 10 sessions Needle usage = 8-20, average 14 per session Typically placed on the scalp, lower abdomen, elbows and knees
Eligibility Criteria
You may qualify if:
- Women aged 18-55 years
- Sexually Active
- Premenopausal
- Documented diagnosis of HSDD as primary cause of FSD (defined as a non adjusted score of ≤ 6 in the desire domain of the FSFI questionnaire)
You may not qualify if:
- Postmenopausal, defined as absence of menstruation in the prior 12 months
- Pain or dyspareunia as the primary cause of FSD (defined as a non adjusted score of ≤ 6 in the pain domain of the FSFI)
- History of hysterectomy and/or oophorectomy
- History of chemotherapy, or pelvic irradiation
- Use of hormonal contraception or oral hormone replacement therapy
- Active skin infection or disease
- Blood dyscrasia
- Allergy to acupuncture needles
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TriHealth Inc.lead
- TriHealth Medical Education Research Fundcollaborator
Study Sites (1)
TriHealth
Cincinnati, Ohio, 45220, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2014
First Posted
February 24, 2014
Study Start
January 1, 2013
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
October 17, 2014
Record last verified: 2014-02